VISKA Trademark

Trademark Overview


On Friday, March 31, 2023, a trademark application was filed for VISKA with the United States Patent and Trademark Office. The USPTO has given the VISKA trademark a serial number of 97867543. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 9, 2024. This trademark is owned by Viska Bio, Inc.. The VISKA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic preparations, pharmaceutical preparations, and vaccines that act as activation immunotherapies for the treatment and prevention of diseases and disorders, namely, aging, atherosclerosis, cancer, congestive heart failure, Nonalcoholic Steatohepatitis (NASH) disease, neurodegenerative diseases, namely, Alzheimers and Parkinsons, obesity, pulmonary fibrosis, and viral diseases, namely, SARS-CoV-2, HIV, influenza, SARS

Research and development of therapeutic preparations, pharmaceuticals, and vaccines
viska

General Information


Serial Number97867543
Word MarkVISKA
Filing DateFriday, March 31, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Goods and ServicesTherapeutic preparations, pharmaceutical preparations, and vaccines that act as activation immunotherapies for the treatment and prevention of diseases and disorders, namely, aging, atherosclerosis, cancer, congestive heart failure, Nonalcoholic Steatohepatitis (NASH) disease, neurodegenerative diseases, namely, Alzheimers and Parkinsons, obesity, pulmonary fibrosis, and viral diseases, namely, SARS-CoV-2, HIV, influenza, SARS
Translation of Words in MarkThe English translation of "VISKA" in the mark is "wisdom".
Goods and ServicesResearch and development of therapeutic preparations, pharmaceuticals, and vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameViska Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameViska Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, April 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 27, 2023ASSIGNED TO EXAMINER
Thursday, March 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 29, 2023NON-FINAL ACTION WRITTEN
Friday, December 29, 2023NON-FINAL ACTION E-MAILED
Friday, December 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT